Opioid Marketing Under Bipartisan Investigation

Attorneys general from a bipartisan group of a majority of U.S. states is launching a joint investigation into the marketing of opioids, the Wall Street Journal reported Wednesday.

The Journal reported that the targets of the investigation are not yet known, but that it will focus on drug manufacturers.

Marketing of the prescription painkillers has been connected with widespread addiction to both legal and illegal drugs, leading to lawsuits against pharmaceutical companies by Ohio last month and Mississippi and New Hampshire in 2015, the Journal reported.

The investigations looked into the practices of Purdue Pharma L.P., Johnson & Johnson (JNJ) , Teva Pharmaceutical Industries Ltd. (TEVA) , Allergan PLC (AGN) , Endo International PLC (ENDP)  and Janssen Pharmaceuticals Inc., according to the Journal.

Mallinckrodt Pharmaceuticals (MNK) , Insys Therapeutics Inc. (INSY) and Mylan Inc. (MYL) are also large producers of opioid painkillers, according to various media reports.

If you liked this article you might like

The Hottest Investing Plays in the Booming Weed Industry for 2018

The Hottest Investing Plays in the Booming Weed Industry for 2018

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report

Best Biotech Stock Trades and Mergers to Watch in 2018

Best Biotech Stock Trades and Mergers to Watch in 2018

California Cannabis Growers Celebrate New Year's Day as Weed Goes Legal

California Cannabis Growers Celebrate New Year's Day as Weed Goes Legal

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers